您的位置：首页 > 产品中心 > 170364-57-5， Enzastaurin
Enzastaurin
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3081105 | 5 MG | 1240 | 2-5天 | 4-6周 | |
| 3081105 | 25 MG | 4550 | 2-5天 | 4-6周 |
产品别名
170364-57-5
Enzastaurin
D04014
LY-317615
3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione
LY317615
基本信息
| Empirical Formula【经验(实验)分子式】 | C32H29N5O2 |
| Molecular weight | 515.60 |
| NACRES | NA.77 |
| Application【应用】 | Enzastaurin has been used in splicing analysis to study its effects on splicing of a mutated exon. |
| Biochem/physiol Actions【生化/生理作用】 | Enzastaurin is a potent and PKCβ preferring inhibitor. Also, Enzastaurin inhibits AKT and GSK3β. Enzastaurin acts as anti-angiogenic and antineoplastic agent. It is an orally administered drug. It can induce apoptosis, inhibit angiogenesis and proliferation of cells. Enzastaurin can be used for the treatment of haematological cancers. |
| Features and Benefits【特点和优势】 | This compound is featured on the GSK-3, PKB/Akt and PKC pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| storage condition【储存条件】 | desiccated |
| color【颜色】 | , light orange to dark orange-red |
| solubility【溶解性】 | DMSO: 10 mg/mL, clear (warmed) |
| storage temp.【储存温度】 | −20℃ |
| InChI | 1S/C32H29N5O2/c1-35-19-25(23-9-2-4-11-27(23)35)29-30(32(39)34-31(29)38)26-20-37(28-12-5-3-10-24(26)28)22-13-16-36(17-14-22)18-21-8-6-7-15-33-21/h2-12,15,19-20,22H,13-14,16-18H2,1H3,(H,34,38,39) |
| InChI key | AXRCEOKUDYDWLF-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 - H413 |
| Precautionary Statements | P273 - P301 + P312 + P330 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Aquatic Chronic 4 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
